These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Neuroendocrine dysfunction and response to tricyclic antidepressants. Kirstein L J Clin Psychiatry; 1984 Sep; 45(9):385-6. PubMed ID: 6432772 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacological treatment of delusional depression]. Amore M; Giordani L; Giorgetti G; Zazzeri N Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200 [TBL] [Abstract][Full Text] [Related]
30. Antidepressant activity of 2-hydroxydesipramine. Nelson JC; Mazure C; Jatlow PI Clin Pharmacol Ther; 1988 Sep; 44(3):283-8. PubMed ID: 3416551 [TBL] [Abstract][Full Text] [Related]
31. Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination? Levitt AJ; Joffe RT; Kamil R; McIntyre R J Clin Psychiatry; 1999 Sep; 60(9):613-6. PubMed ID: 10520980 [TBL] [Abstract][Full Text] [Related]
32. 2-Hydroxydesipramine and desipramine plasma levels: how are they related to antidepressant response? Stern SL; Cooper TB; Nelson LD; Johnson MH; Suckow RF Int Clin Psychopharmacol; 1996 Dec; 11(4):219-27. PubMed ID: 9031987 [TBL] [Abstract][Full Text] [Related]
33. Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response. Swann AC; Bowden CL; Rush AJ; Rhoades H; Rose R; Kobes R J Clin Psychopharmacol; 1997 Apr; 17(2):78-83. PubMed ID: 10950467 [TBL] [Abstract][Full Text] [Related]
34. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study. Cappiello A; McDougle CJ; Delgado PL; Malison RT; Jatlow P; Charney DS; Heninger GR; Price LH Int Clin Psychopharmacol; 1998 Sep; 13(5):191-8. PubMed ID: 9817623 [TBL] [Abstract][Full Text] [Related]
35. Drug-responsive symptoms in melancholia. Nelson JC; Mazure C; Quinlan DM; Jatlow PI Arch Gen Psychiatry; 1984 Jul; 41(7):663-8. PubMed ID: 6732425 [TBL] [Abstract][Full Text] [Related]
36. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. Mason BJ; Kocsis JH; Ritvo EC; Cutler RB JAMA; 1996 Mar; 275(10):761-7. PubMed ID: 8598592 [TBL] [Abstract][Full Text] [Related]
37. Cognitive improvement associated with tricyclic antidepressant treatment of childhood major depressive illness. Staton RD; Wilson H; Brumback RA Percept Mot Skills; 1981 Aug; 53(1):219-34. PubMed ID: 7290870 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness. Stewart JW; Quitkin FM; Liebowitz MR; McGrath PJ; Harrison WM; Klein DF Arch Gen Psychiatry; 1983 Feb; 40(2):202-7. PubMed ID: 6337580 [TBL] [Abstract][Full Text] [Related]
39. Predictors of response to desipramine in dysthymia. Friedman RA; Parides M; Baff R; Moran M; Kocsis JH J Clin Psychopharmacol; 1995 Aug; 15(4):280-3. PubMed ID: 7593711 [TBL] [Abstract][Full Text] [Related]
40. Effect of DSM-III personality disorders on outcome of tricyclic antidepressant-treated nonpsychotic outpatients with major or minor depressive disorder. Reich JH Psychiatry Res; 1990 May; 32(2):175-81. PubMed ID: 2367602 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]